| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.33 | 5e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |